Scintimammography
| Scintimammography | |
|---|---|
| Diagnostics | |
| File:Tc99m-sestamibi.jpg | |
| ICD-10-PCS | CH1 |
| ICD-9-CM | 92.19 |
| HCPCS-L2 | S8080 |
Scintimammography, also known as nuclear medicine breast imaging, breast specific gamma imaging or molecular breast imaging,[1] is a type of breast imaging test that is used to detect cancer cells in the breasts of some women who have had abnormal mammograms, or for those who have dense breast tissue, post-operative scar tissue or breast implants, but is not used for screening or in place of a mammogram. Rather, it is used when the detection of breast abnormalities is not possible or not reliable on the basis of mammography and ultrasound. In the scintimammography procedure, a woman receives an injection of a small amount of a radioactive substance called technetium 99 sestamibi,[2] which is taken up by cancer cells, and a gamma camera is used to take pictures of the breasts.
Also called a Miraluma test (when with sestamibi)[3] and sestamibi breast imaging.
See also
References
External links
- Scintimammography entry in the public domain NCI Dictionary of Cancer Terms
This article incorporates public domain material from the U.S. National Cancer Institute document "Dictionary of Cancer Terms".
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This oncology article is a stub. You can help Wikipedia by expanding it. |
